Stories

What is Explorers’ World? Short videos about French entrepreneurs sharing their international success. Today we are welcoming Jérôme Hubert, Chairman of Pinette P.E.I.

Lydia has joined France’s growing stable of unicorns, securing a $103 million investment round in December to reach the prized $1 billion threshold. Founded in 2013 as a revolutionary P2P payment method via an app, the Fintech leader has since grown to encompass a full spectrum of financial services, from micro loans to stock and crypto trading.

Explorers’ Words highlight the story of French entrepreneurs who decided to go abroad and have succeeded to expand their business. Benjamin Saada, co-founder and chairman of Expliseat is our guest today.

Explorers’ Words tell the success of French entrepreneurs who dared to turn global. They share their experience and some advice to future world explorers. In today’s episode we are meeting, Olivier Desurmont, CEO and co-founder of Cooptalis.

Explorers’ Words bring to light the success of French entrepreneurs who decided to go abroad. Today we are welcoming Philippe Granié, Managing Director of AIT-STEIN Group.

Swile recently reached unicorn status after raising $200 million, just four years after its launch. The French startup, which provides a payment card for digital meal vouchers and other employee benefits to companies, is now expanding its international presence as its Chief Operating Officer Grégory Gazagne explains.

Explorers’ Words emphasizes how French entrepreneurs throw themselves into exportation.  Today’s guest is Olivier Meyer, CEO of Style & Design which supports companies in their design process.

Explorers’ Words highlight French entrepreneurs’ success stories abroad. Today’s guest is Dominique Lupinski, owner of Cristal Laser, which synthesizes crystals that have optical properties for lasers.

Explorers’ Words highlight French entrepreneurs’ success stories abroad. Today’s guest is Raphaël de Tramasure, Associate Director of FSE Group, which is an integrator-engineer specialized in hospital equipment’s projects worldwide.

Founded in 2013, Inotrem is working on groundbreaking immunotherapies against life-threatening inflammatory syndromes. Backed by European and North American investors, as well as the French government, the biotech company is conducting a key phase of clinical trials on its lead drug candidate ‘nangibotide’ and working on other compounds that could save millions of lives.